Increasing Prevalence of Lifestyle Disorders & Rising Geriatric Population Have Led To a High Number of Diabetics, Thereby Driving Insulin Storage Devices Market Expansion
Seoul, South Korea, Aug. 02, 2022 (GLOBE NEWSWIRE) -- Sales of insulin storage devices across the world are predicted to increase at a CAGR of 8.1% across the forecast period (2022-2027). In 2022, the global insulin storage devices market accounts for a revenue of US$ 798 million and is predicted to reach US$ 1.28 billion by the end of 2027. Fact.MR, a market research and competitive intelligence provider, has discussed all the key trends, restraints, and opportunities governing market growth, in this latest insulin storage devices market research study.
Poor eating habits and increasingly sedentary lifestyles have led to an increased prevalence of lifestyle disorders, of which, diabetes is a particularly concerning one. Over the past few years, the incidence of diabetes has risen rapidly and is projected to increase faster going forward. This is expected to drive the use of insulin among diabetic patients and subsequently increase the usage of insulin storage devices through 2027.
For Critical Insights on Insulin Storage Devices Market, Request a Sample Report https://www.factmr.com/connectus/sample?flag=S&rep_id=7568
Insulin storage device manufacturers are expected to focus on the expansion of their product portfolios by launching new products to gain a competitive edge over their competitors.
In July 2022, Godrej Appliances, an Indian multinational conglomerate, announced the launch of a new product range to provide new cooling solutions for insulin storage. Godrej InsuliCool and Godrej InsuliCool+ were launched to provide diabetic patients with better storage for their insulin.
Which Product Type is Set to Be Highly Sought-after across Geographies?
“Battery-operated Insulin Devices to Account for Major Market Share”
The global insulin storage devices market based on product type is segmented into insulated kits and battery-powered insulin storage devices. The insulated kits segment is further bifurcated into insulin cooling wallets, insulin cooling pouches, and insulated cooler bags.
Battery-powered insulin devices hold a prominent market share and are expected to maintain a similar stance across the forecast period as well. Benefits such as longer battery life, portability, and ease of use are expected to bolster demand for battery-powered insulin devices through 2027.
Insulated kits are anticipated to witness an increase in demand at an approximate CAGR of 7% across the forecast period. The rising geriatric population is anticipated to drive sales of insulated cooling wallets, insulated cooling pouches, etc. over the coming years.
To learn more about Insulin Storage Devices Market, you can get in touch with our Analyst at https://www.factmr.com/connectus/sample?flag=AE&rep_id=7568
Key Segments Covered in the Insulin Storage Devices Industry Survey
Insulin storage device manufacturers are anticipated to increase investments in product development and launch new products to expand their sales potential. Insulin storage device companies are also expected to adopt innovative marketing strategies to increase awareness about diabetes and bolster sales of insulin storage devices through 2027.
This latest insulin storage devices market survey by Fact.MR, a market research and competitive intelligence provider, consists of key companies such as ReadyCare LLC, DISIONCARE, Medicool, Tawa Outdoor, Cooluli, and Arkray Inc., among others, to give a comprehensive account of the global competitive landscape.
Get Customization on Insulin Storage Devices Market Report for Specific Research Solutions https://www.factmr.com/connectus/sample?flag=RC&rep_id=7568
Key players in the Insulin Storage Devices Market
Zhengzhou Olive Electronic Technology Co. Ltd.
Key Takeaways from Insulin Storage Devices Market Study
The global insulin storage devices market is currently valued at US$ 798 million.
Sales of insulin storage devices are expected to increase at 8.1% CAGR through 2027.
By 2027, the insulin storage devices market is expected to reach US$ 1.28 billion.
Rising geriatric population, increasing awareness about diabetes, growing consumption of refined & processed foods, and rising prevalence of lifestyle disorders are key factors that are expected to increase the need for insulin storage systems.
Demand for insulin storage devices in Germany is predicted to increase at a CAGR of 5% from 2022 to 2027.
The China insulin storage devices market is projected to reach US$ 285 million by the end of 2027, expanding at a high CAGR of 12%.
Fact.MR’s Domain Expertise in Healthcare Sector
Our healthcare consulting team guides organizations at each step of their business strategy by helping you understand how the latest influencers account for operational and strategic transformation in the healthcare sector. Our expertise in recognizing the challenges and trends impacting the global healthcare industry provides indispensable insights and support - encasing a strategic perspective that helps you identify critical issues and devise appropriate solutions.
Explore Fact.MR's Coverage on the Healthcare Domain-
Healthcare Contract Research Organization Market - The global sales of healthcare contract research organization garnered a market value of US$ 44 Billion in 2022 and is expected to register a CAGR of 6% by accumulating a market value of US$ 79 Billion through the assessment period 2022-2032.
Parenteral Nutrition Market - The industry is expected to reach US$ 7 Billion by 2022-end, experiencing Y-o-Y increase of 16% compared to 2021. From 2022-2032, the industry is forecast to increase 2x to reach US$ 14 Billion.
Biotechnology & Pharmaceutical Services Outsourcing Market - The global biotechnology and pharmaceutical services outsourcing market is anticipated to hold a market value of US$ 70 Billion in 2022 and US$ 112.31 Billion by 2032.
Electronic Health Records Market - The electronic health records market is expected to garner a market value of US$ 26.78 Billion in 2022, anticipated to register a positive CAGR of 4.5% in the forecast period 2022-2032 and reach a value of US$ 41.8 Billion.
Veterinary Artificial Insemination Market - The veterinary artificial insemination market is forecast to garner a market value of US$ 3.16 Billion in 2022, anticipated to register a positive CAGR of 5.2% in the forecast period 2022-2032 and reach a value of US$ 5.24 Bn.
Amniotic Membrane Market - The global amniotic membrane market is estimated to hold a value of US$ 11.12 Billion in 2032 and is expected to expand at a CAGR of 14% during the forecast period from 2022 to 2032.
Drug Delivery Systems Market- The worldwide drug delivery systems market was worth around US$ 40 Billion in 2022 and is expected to grow at a CAGR of more than 7.8% from 2022 to 2032, reaching roughly US$ 80 Billion by 2032.
Medical Waste Management Market- The global medical waste management market, which projects market growth at a CAGR of 6.2% from 2021 to 2028. Revenue from medical waste management services accounted for US$ 15.3 Billion in 2020, and is estimated to surge to US$ 25.2 Billion by the end of 2028.
Heart Attack Diagnostics Market- The heart attack diagnostics market is predicted to grow at a moderate CAGR of 7.1% during the forecast period of 2022 to 2032. The global heart attack diagnostics market is estimated to reach a value of nearly US$ 22.2 Billion by 2032 by growing from US$ 10.4 Billion in 2021.
Drug Discovery Services Market- The drug discovery services market is forecasted to reach US$ 50 Billion by 2032, up from US$ 19 Billion in 2022, at a CAGR of 10.1%. A Y-o-Y growth rate of nearly 12% is expected for the market in 2022. As of 2021, the market was valued at US$ 17 Billion.
About Us: Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact: Mahendra Singh US Sales Office: 11140 Rockville Pike Suite 400 Rockville, MD 20852 Email: sales@factmr.com Tel: +1 (628) 251-1583 Follow Us: LinkedIn | Twitter
In this article, we discuss the 5 stocks that Warren Buffett is buying on the dip. If you want to see more stocks in this selection, click Warren Buffett is Buying the Dip on These 3 Stocks. Berkshire Hathaway’s Warren Buffett went on a buying spree despite the turmoil in the global equity markets. In […]
The stock rose as much as 272% but is up about 175% as of 1:25 p.m. ET. The tech stock's gain came on the day of its initial public offering (IPO). Given the way the stock is soaring, the market apparently thinks the IPO was underpriced.
Shares of StoneCo (NASDAQ: STNE), a cloud-based technology platform, plummeted Friday morning after the company reported its second-quarter results, which disappointed investors, and announced yet another shift to its management team. The company reported non-GAAP (adjusted) earnings of 0.25 Brazilian reals (equivalent to $0.05), which was an increase from a loss of 0.48 reals in the year-ago quarter, but was below Wall Street's consensus estimate of about 0.57 reals, or $0.11 per share. StoneCo's revenue in the quarter was 2.3 billion reals (about $442 million), 5% higher than the company's guidance, and up 275% from the year-ago quarter.
The Federal Energy Regulatory Commission filing could mean that Berkshire Hathaway will continue to increase its stake in Occidental.
When President Joe Biden signed the CHIPS Act of 2022 into law on Aug. 9, it provided some good news for a number of chip stocks.
A 20-year-old USC student has made a $110 million profit from trading meme stock favorite Bed Bath & Beyond, following a frenzy in Wednesday’s trading session.
A lot of surprising companies are paring back their payrolls lately. Some of them should bounce back soon.
Verizon (VZ) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Back up the EV on shares of General Motors, says this one analyst.
Jake Freeman cashed out his 6% stake in the meme stock after it exploded on Tuesday.
(Bloomberg) -- Warren Buffett’s Berkshire Hathaway Inc. won approval from US regulators to buy as much as 50% of Occidental Petroleum Corp. after spending months acquiring its shares. Occidental’s shares surged on news of the authorization.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesStocks Slide as Short-Sellers Cash In on Fedspeak: Markets WrapCo
(Reuters) -A U.S. energy regulator on Friday gave Berkshire Hathaway Inc, the company controlled by billionaire Warren Buffett, permission to buy up to 50% of oil company Occidental Petroleum Corp's common stock. The Federal Energy Regulatory Commission (FERC) said its authorization was "consistent with the public interest," after Berkshire said a larger stake would not hurt competition, undermine regulatory authority, or boost costs for consumers. Occidental shares soared as much as 11.7%, and in midafternoon trading were up $6.06, or 9.3%, at $70.94.
For investors looking to maximize their wealth by the time they retire, the following pair of beaten-down businesses that possess strong growth capabilities are a worthwhile place to start. Freelance marketplace operator Fiverr (NYSE: FVRR) was a pandemic-lockdown superstar. Although Fiverr's stock price is down 65% in 2022 and off 82% from its all-time high, the freelance shop is still growing, albeit at a slower rate as SMBs became more cautious due to rampant inflation and rising energy costs and interest rates.
(Bloomberg) -- Gazprom PJSC will stop delivering natural gas to Europe through its main pipeline for three days, further squeezing energy supplies just as Germany is trying to build up stocks for the winter.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesStocks Slide as Short-Sellers Cash In on Fedspeak: Markets WrapCovid’s Harmful Effects on the Brai
(Bloomberg) -- Billionaire Ryan Cohen pocketed a $68.1 million profit from the sale of his stake in Bed Bath & Beyond Inc., scoring a 56% gain on an investment he held for roughly seven months.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesStocks Slide as Short-Sellers Cash In on Fedspeak: Markets WrapCovid’s Harmful Effects on the Brain Reverberate
JPMorgan Chase & Co. (JPM) closed at $121.64 in the latest trading session, marking a -0.77% move from the prior day.
Households can expect to pay more to heat their homes this winter. “Natural gas futures prices are more than double what they were one year ago,” according to Andy Lipow of Lipow Oil Associates.
In this article, we discuss 10 Cathie Wood stocks to buy before the bull run starts. If you want to see more stocks preferred by Cathie Wood to load up on before the bull run begins, click 5 Cathie Wood Stocks to Buy Before the Bull Run Starts. Cathie Wood, the founder and CIO of […]
(Bloomberg) -- Wells Fargo & Co. bungled the 2020 sale of Occidental Petroleum Corp. shares on behalf of an employee trust, leading to millions of dollars in losses when the bank failed to execute trades as planned before the Covid-19 pandemic tanked the stock market, a judge in Texas ruled.Most Read from BloombergUS Mortgage Lenders Are Starting to Go BrokeXi and Putin to Attend G-20 Summit in Indonesia, Jokowi SaysApple Targets Sept. 7 for iPhone 14 Launch in Flurry of New DevicesStocks Slide
A Seattle CEO who announced in 2015 that he was giving himself a drastic pay cut to help cover the cost of big raises for his employees has announced his resignation.